Natixis Zimmer Biomet Holdings, Inc. Transaction History

Natixis

  • $17.6 Billion
  • Q3 2024

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
$106.25 - $130.01 $8.93 Million - $10.9 Million
-84,011 Reduced 81.53%
19,028 $2.07 Million
Q1 2024

May 13, 2024
BUY
$119.98 - $132.61 $12.4 Million - $13.7 Million
103,039 New
103,039 $13.6 Million
Q3 2023

Nov 14, 2023
BUY
$110.76 - $143.18 $11.2 Million - $14.4 Million
100,916 Added 787.61%
113,729 $12.8 Million
Q2 2023

Aug 11, 2023
BUY
$126.43 - $145.6 $755,292 - $869,814
5,974 Added 87.35%
12,813 $1.87 Million
Q1 2023

May 12, 2023
SELL
$121.91 - $130.94 $2.63 Million - $2.83 Million
-21,576 Reduced 75.93%
6,839 $883,000
Q4 2022

Feb 24, 2023
BUY
$104.7 - $128.4 $533,341 - $654,069
5,094 Added 21.84%
28,415 $3.62 Million
Q4 2022

Feb 13, 2023
BUY
$104.7 - $128.4 $1.06 Million - $1.3 Million
10,161 Added 77.21%
23,321 $2.97 Million
Q3 2022

Nov 14, 2022
BUY
$101.65 - $119.27 $412,190 - $483,639
4,055 Added 44.54%
13,160 $1.38 Million
Q2 2022

Aug 12, 2022
SELL
$102.23 - $133.85 $30.7 Million - $40.2 Million
-300,335 Reduced 97.06%
9,105 $957,000
Q1 2022

May 13, 2022
BUY
$108.42 - $129.58 $33.5 Million - $40.1 Million
309,440 New
309,440 $39.6 Million
Q4 2021

Feb 14, 2022
SELL
$115.43 - $146.63 $306,466 - $389,302
-2,655 Closed
0 $0
Q3 2021

Nov 12, 2021
BUY
$136.35 - $158.76 $362,009 - $421,507
2,655 New
2,655 $389,000
Q2 2021

Aug 13, 2021
SELL
$152.95 - $173.41 $745,325 - $845,026
-4,873 Closed
0 $0
Q1 2021

May 14, 2021
SELL
$148.16 - $159.71 $18.8 Million - $20.3 Million
-126,935 Reduced 96.3%
4,873 $780,000
Q4 2020

Feb 12, 2021
BUY
$128.25 - $151.41 $16.9 Million - $20 Million
131,808 New
131,808 $20.3 Million
Q3 2020

Nov 12, 2020
SELL
$113.59 - $141.68 $3.39 Million - $4.22 Million
-29,801 Closed
0 $0
Q2 2020

Aug 13, 2020
SELL
$87.02 - $133.4 $6.08 Million - $9.32 Million
-69,849 Reduced 70.09%
29,801 $3.56 Million
Q1 2020

May 14, 2020
BUY
$78.28 - $155.73 $7.05 Million - $14 Million
90,097 Added 943.13%
99,650 $10.1 Million
Q4 2019

Feb 14, 2020
BUY
$127.4 - $146.83 $527,690 - $608,169
4,142 Added 76.55%
9,553 $1.42 Million
Q2 2019

Aug 13, 2019
BUY
$108.87 - $125.09 $589,095 - $676,861
5,411 New
5,411 $637,000
Q1 2019

May 15, 2019
SELL
$97.5 - $125.79 $26.9 Million - $34.8 Million
-276,310 Closed
0 $0
Q4 2018

Feb 14, 2019
BUY
$94.4 - $126.76 $25.7 Million - $34.5 Million
272,313 Added 6812.93%
276,310 $28.7 Million
Q3 2018

Nov 14, 2018
SELL
$108.41 - $127.64 $15.9 Million - $18.8 Million
-147,027 Reduced 97.35%
3,997 $525,000
Q2 2018

Aug 14, 2018
BUY
$102.12 - $114.04 $3.16 Million - $3.53 Million
30,988 Added 25.82%
151,024 $16.8 Million
Q1 2018

May 15, 2018
BUY
$104.31 - $124.46 $11.5 Million - $13.7 Million
110,259 Added 1127.74%
120,036 $13.1 Million
Q4 2017

Feb 14, 2018
BUY
$105.55 - $120.83 $1.03 Million - $1.18 Million
9,777 New
9,777 $1.18 Million
Q3 2017

Nov 14, 2017
SELL
$106.92 - $117.79 $2.52 Million - $2.78 Million
-23,587 Closed
0 $0
Q2 2017

Aug 14, 2017
BUY
N/A
23,587
23,587 $3.03 Million

Others Institutions Holding ZBH

# of Institutions
1,080
Shares Held
179M
Call Options Held
301K
Put Options Held
1M
View Full List

About ZIMMER BIOMET HOLDINGS, INC.

ZBH Quotes by TradingView
  • Ticker ZBH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 209,820,000
  • Market Cap $23.1B
  • Description
  • Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs, manufactures, and markets orthopaedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, bi...
More about ZBH
Track This Portfolio

Track Natixis Portfolio

Follow Natixis and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis, based on Form 13F filings with the SEC.

News

Stay updated on Natixis with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email